About Ivonescimab Ivonescimab is the most advanced PD-1/VEGF bispecific antibody in clinical development in the U.S.,…
About Olaparib Olaparib is a poly (ADP ribose) polymerase (PARP) inhibitor, at least before monotherapy Germline…
About Fruquintinib Fruquintinib (Fruzaqla) sold under the brand name 爱优特 in china, is an oral, highly selective,…
About Toripalimab Toripalimab-tpzi is a next generation anti-PD-1 monoclonal antibody that blocks PD-L1 binding to the…
About Glumetinib or Gumarontinib Glumetinib (SCC244) also named Gumarontinib, is a highly selective, orally bioavailable, ATP-competitive c-Met…
About Adagrasib Adagrasib is a prescription medicine used in adults: alone to treat non-small cell lung…
About Cejemly® (Sugemalimab) The anti-PD-L1 monoclonal antibody sugemalimab was discovered by CStone using the OmniRat® transgenic animal…
About Pralsetinib Pralsetinib is a tyrosine kinase inhibitor. It is taken by mouth. Pralsetinib is a medication approved for RET mutation-positive medullary…